Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;13(1):291-307.
doi: 10.1080/21655979.2021.2000724.

Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression

Affiliations

Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression

Jun Zhang et al. Bioengineered. 2022 Jan.

Abstract

Breast cancer is the most common malignancy in females and poses a significant health threat to women. Pregnancy-associated plasma protein-A (PAPPA) is highly expressed in pregnancy-associated breast cancer (PABC) tissues. In this study, we investigated the functional role of PAPPA in regulating the malignant phenotype of breast cancer. We first examined the expression level of PAPPA in PABC tissue and breast cancer cell lines using quantitative real-time polymerase-chain reaction (qRT-PCR) and western blot. Next, the functional role of PAPPA in breast cancer cells was validated by overexpression and knockdown experiments. Cell counting kit-8 (CCK-8) proliferation assay, 5-ethynyl-2'-deoxyuridine (EdU) incorporation assay, wound healing and transwell invasion assay were used to examine cell proliferation, migration, and invasion ability. We further identified the microRNA target regulating PAPPA and studied its functional role. Finally, we examined the impact of PAPPA on the tumorigenesis and metastasis of breast cancer in mice model. Our study revealed that PAPPA was upregulated in PABC tissues and breast cancer cells. Overexpression of PAPPA promoted cell proliferation, motility, invasion, and epithelial-mesenchymal transition (EMT). We further identified miR-497-5p as a negative regulator of PAPPA, which suppressed cell proliferation, migration, invasion, and EMT in breast cancer cells. We also validated the oncogenic role of PAPPA in the mouse xenograft model. Collectively, our study suggests that PAPPA is an oncogenic protein highly expressed in PABC tissues and promotes breast cancer progression, which could serve as a novel therapeutic target for breast cancer.

Keywords: MCF7; MDA-MB-231; PABC; PAPPA; miR-497-5p.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1.
Figure 1.
PAPPA was highly expressed in pregnancy-associated breast cancer (PABC) tissues and cells.
Figure 2.
Figure 2.
Overexpression of PAPPA promoted proliferation, migration and invasion of breast cancer cells.
Figure 3.
Figure 3.
Knocking down PAPPA inhibited the proliferation, migration and invasion of breast cancer cells.
Figure 4.
Figure 4.
Migratory capability of breast cancer cells is enhanced by co-culture with PAPPA-rich serum.
Figure 5.
Figure 5.
MiR-497-5p negatively targeted PAPPA.
Figure 6.
Figure 6.
Overexpression of PAPPA rescued the inhibitory effect of miR-497-5p on the proliferation, migration and invasion of breast cancer cells.
Figure 7.
Figure 7.
PAPPA promoted tumorigenesis and metastasis of breast cancer cells in vivo.

Similar articles

Cited by

References

    1. Veronesi U, Boyle P, Goldhirsch A, et al. Breast cancer. Lancet. 2005;365(9472):1727–1741. - PubMed
    1. DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61(6):409–418. - PubMed
    1. Liang Y, Zhang H, Song X, et al. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14–27. - PubMed
    1. Peairs KS, Choi Y, Stewart RW, et al. Screening for breast cancer. Semin Oncol. 2017;44(1):60–72. - PubMed
    1. Braden AM, Stankowski RV, Engel JM, et al. Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. Curr Pharm Des. 2014;20(30):4879–4898. - PubMed

MeSH terms